Medicare Enrolled

Dr. Rakesh Shah, M.D.

Neurology · New Port Richey, FL
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Consulting-driven
4762 ROWAN RD, New Port Richey, FL 34653
7278480800
In practice since 2005 (20 years)
NPI: 1497748719 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Shah from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Shah? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Shah

Dr. Rakesh Shah is a neurology in New Port Richey, FL, with 20 years in practice. Based on federal Medicare data, Dr. Shah performed 4,773 Medicare services across 1,370 unique beneficiaries.

Between the years covered by Open Payments, Dr. Shah received a total of $9,635 from 41 pharmaceutical and/or device companies across 229 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neurology. The majority of payments are for consulting, which typically reflects recognized clinical expertise sought by manufacturers. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Shah is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice▲ Top 15% volume in FL$ $9,635 industry payments

Medicare Practice Summary

Medicare Utilization ↗
4,773
Medicare services
Top 15% in FL for neurology
1,370
Unique beneficiaries
$77
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~239 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Hospital follow-up visit, moderate complexity3,200$62$200
Hospital follow-up visit, high complexity404$94$225
Office visit, established patient (30-39 min)381$94$200
Initial hospital admission, high complexity232$134$450
New patient office visit (45-59 min)164$120$450
Initial hospital admission, moderate complexity110$97$400
Measurement of brain wave activity (eeg), awake and drowsy70$43$200
Needle measurement of electrical activity in arm or leg muscles, complete study69$75$200
Nerve conduction, 13 or more studies61$220$1,600
Office visit, established patient (20-29 min)41$63$175
Measurement of brain wave activity (eeg), 61-119 minutes22$324$1,000
Critical care, first 30-74 min19$170$550
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$9,635
Total received (2018-2024)
Avg $1,376/year across 7 years
Top 28% in FL for neurology
41
Companies
229
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$5,031 (52.2%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$3,444 (35.7%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$1,160 (12.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$891
2023
$1,203
2022
$331
2021
$236
2020
$96
2019
$251
2018
$6,627

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Bayer HealthCare Pharmaceuticals Inc.
$5,031
GENZYME CORPORATION
$1,192
EMD Serono, Inc.
$512
Biogen, Inc.
$278
Teva Pharmaceuticals USA, Inc.
$249
AbbVie Inc.
$220
UCB, Inc.
$217
Sumitomo Pharma America, Inc.
$202
ABBVIE INC.
$150
Eisai Inc.
$141
Neurocrine Biosciences, Inc.
$135
Sunovion Pharmaceuticals Inc.
$113
Boston Scientific Corporation
$101
Mallinckrodt Hospital Products Inc.
$95
GE Healthcare
$90
Abbott Laboratories
$87
CATALYST PHARMACEUTICALS, INC.
$72
Celgene Corporation
$59
Lundbeck LLC
$57
ARGENX US, INC.
$54
Janssen Pharmaceuticals, Inc
$51
Corium, LLC
$49
BANNER LIFE SCIENCES, LLC
$49
Vanda Pharmaceuticals Inc.
$48
MITSUBISHI TANABE PHARMA AMERICA, INC.
$45
E.R. Squibb & Sons, L.L.C.
$44
Novartis Pharmaceuticals Corporation
$39
Alexion Pharmaceuticals, Inc.
$31
Catalyst Pharmaceuticals, Inc.
$31
TG Therapeutics, Inc.
$25
Otsuka America Pharmaceutical, Inc.
$22
Banner Life Sciences, LLC
$22
Lilly USA, LLC
$19
SK Life Science, Inc.
$18
Mallinckrodt Enterprises LLC
$17
Supernus Pharmaceuticals, Inc.
$16
Biohaven Pharmaceutical Holding Company Ltd.
$15
PFIZER INC.
$12
Horizon Therapeutics plc
$12
Amgen Inc.
$11
Cycle Pharmaceuticals Inc
$5
Top 3 companies account for 69.9% of total payments
Associated products mentioned in payments ›
ACTHAR · ADLARITY · AJOVY · AMYVID · APTIOM · AUBAGIO · AUSTEDO · AVONEX · Aimovig · Austedo XR · BAFIERTAM · BRIUMVI · Betaseron · Briviact · COPAXONE · FYCOMPA · Fycompa · GILENYA · INGREZZA · KESIMPTA · KYNMOBI · LEMTRADA · LYRICA · Leqembi · MAVENCLAD · MITRACLIP · Mavenclad · NURTEC ODT · Nayzilam · Ongentys · PERCLOSE PROGLIDE · PONVORY · Ponvory · QULIPTA · RADICAVA · REXULTI · Rebif · Rystiggo · SOLIRIS · SPINRAZA · TECFIDERA · TROKENDI XR · TYSABRI · Tascenso ODT · UBRELVY · UPLIZNA · VUMERITY · VYEPTI · VYVGART · XCOPRI · ZEPOSIA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (52%) are consulting fees, which typically reflect recognized clinical expertise sought by manufacturers.

Equivalent to $202 per 100 Medicare services performed
Looking for a neurology in New Port Richey?
Compare neurologys in the New Port Richey area by procedure volume, costs, and industry payment transparency.
Browse neurologys nearby

Geographic Context

Neurologys within 10 mi
147
Per 100K population
25.0
County median income
$67,384
Nearest hospital
HCA FLORIDA TRINITY HOSPITAL
3.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Shah is a mixed practice specialist, with above-average Medicare volume (top 15% in FL), and consulting-driven industry engagement, with 20 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Shah experienced with hospital follow-up visit, moderate complexity?
Based on Medicare claims data, Dr. Shah performed 3,200 hospital follow-up visit, moderate complexity services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Shah receive payments from pharmaceutical companies?
Yes. Dr. Shah received a total of $9,635 from 41 companies across 229 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Shah's costs compare to other neurologys in New Port Richey?
Dr. Shah's average Medicare payment per service is $77. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Shah) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →